This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Nov 7;391(18):1757.

doi: 10.1056/NEJMc2410532.

Semaglutide for Chronic Kidney Disease in Type 2 Diabetes

Rogerio da Hora Passos¹, Roberto Camargo Narciso¹, Arnaldo Alves da Silva¹

Affiliations

PMID: 39504528
DOI: 10.1056/NEJMc2410532

Comment

Semaglutide for Chronic Kidney Disease in Type 2 Diabetes

Rogerio da Hora Passos et al. N Engl J Med. 2024.

. 2024 Nov 7;391(18):1757.

doi: 10.1056/NEJMc2410532.

Authors

Rogerio da Hora Passos¹, Roberto Camargo Narciso¹, Arnaldo Alves da Silva¹

Affiliation

¹ Hospital Israelita Albert Einstein, São Paulo, Brazil oiregorpassos@yahoo.com.br.

PMID: 39504528
DOI: 10.1056/NEJMc2410532

No abstract available

PubMed Disclaimer

Comment on

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, Baeres FMM, Idorn T, Bosch-Traberg H, Lausvig NL, Pratley R; FLOW Trial Committees and Investigators. Perkovic V, et al. N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24. N Engl J Med. 2024. PMID: 38785209 Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.